We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

24 Aug 2018 07:00

RNS Number : 7494Y
F&C Private Equity Trust PLC
24 August 2018
 

To: Stock Exchange

For immediate release:

 

24 August 2018

 

F&C Private Equity Trust plc

LEI: 2138009FW98WZFCGRN66

 

Unaudited results for the half year to 30 June 2018

Financial Highlights

 

· Share price total return for the six months of 3.6 per cent for the Ordinary Shares.

 

· NAV total return for the six months of 1.7 per cent for the Ordinary Shares.

 

· Total quarterly dividends of 7.14p per Ordinary Share.

 

· Quarterly dividend of 3.57p paid on 31 July 2018

· Quarterly dividend of 3.57p to be paid on 31 October 2018

 

· Dividend yield of 4.2 per cent based on the period end share price (1).

 

Chairman's Statement

 

As at 30 June 2018 the Net Assets of the Company were £263.4 million, giving a Net Asset Value (NAV) per share of 356.17p. Taking account of dividends paid, the NAV total return for the six-month period was 1.7 per cent. With the discount to NAV per share reducing to 3.4 per cent as at 30 June 2018 in comparison to 5.1 per cent as at 31 December 2017, the share price total return for the six-month period was 3.6 per cent. At the end of the period the Company had cash of £7.0 million. Together with borrowings of £26.3 million under the Company's loan facility, net debt was £19.3 million, equivalent to a gearing level of 6.8 per cent (2). It is the Company's policy to employ moderate levels of gearing to enhance returns to shareholders. The total of outstanding undrawn commitments at 30 June 2018 was £142.4 million and, of this, approximately £16.7 million is to funds where the investment period has expired.

 

In accordance with the Company's stated dividend policy, the Board declares a quarterly dividend of 3.57p per ordinary share, payable on 31 October 2018 to shareholders on the register on 5 October 2018. For illustrative purposes only, this dividend and that paid on 31 July 2018 represent an annualised yield of 4.2 per cent based on the share price as at 30 June 2018. I would like to remind shareholders of our dividend re-investment plan, which can be a convenient and easy way to build up an existing holding.

 

There has been a considerable amount of portfolio activity for the Company in the first half of the year with several new co-investments as well as both primary and secondary fund positions added. The total of new investments is £40.6 million. The flow of realisations continues with £29.9 million coming in during the period. Your Company has a naturally dynamic portfolio which is essential to maintain excellent exposure to a range of investments across sectors and geographies led by our investment partners.

 

 

 

Mark Tennant

Chairman

 

Manager's Review

 

New Investments

This has been an active first half for new investments with five primary fund commitments, one secondary and five co-investments made. £21.9 million has been invested in co-investments, including add ons, £3.8 million has been invested in secondaries and a further £14.9 million has been drawn by funds giving a total for the first half of £40.6 million. This compares with £31.6 million at the same point in 2017.

 

In the earlier part of the period new commitments were made to Verdane Edda (£4.3 million), a Nordic fund focusing on technology enabled companies, Apiary Capital Partners I (£5.0 million), a new UK fund focusing on the lower mid-market and Volpi Capital I (£6.2 million), a Northern Europe focused technology enabled growth fund. We also invested in secondary. This fund, NEM Impresse III (£3.8 million), has spun out of the Banco Populare de Vicenza.

 

More recently two new fund commitments were made to Inflexion Buyout Fund V (£4.0 million) and Inflexion Partnership Capital Fund II (£3.5 million). These funds represent our latest involvement in the highly successful Inflexion franchise. This has been an important relationship for us since 2003, however including all the fund positions and the latest co-investment our exposure to Inflexion is £20.8 million or just over 7 per cent of total investments. The Inflexion Buyout Fund V continues with their focus on lower mid-market buyouts in the UK and the Inflexion Partnership Capital Fund is for minority investments in somewhat larger companies.

 

Five new co-investments have been added to the portfolio during the first half of the year. The proportion invested in co-investments is now 37.5 per cent, up from 32.5 per cent at the beginning of the year. This proportion has been rising slowly in accordance with the Company's strategy. All these investments are preceded by a considerable period of diligence and preparation and the exact timing of the initial investment depends on a number of factors.

 

£2.2 million has been invested with another £1.8 million committed to Pet Centar, the Croatia based large format pet store chain. Since the initial investment in April the planned acquisition of the Romania based business Animax has been completed and there has been a drawdown of £1.3 million. Pet Centar is also about to acquire Slovenia based Mr Pet. The Rohatyn Group have completed the management team for the company.

 

Rosa Mexicano, the 'polished casual' Mexican themed US restaurant chain which has been acquired by hospitality specialists Trispan was added to the portfolio in April with our £3.7 million investment for 13.7% of the company.

 

A commitment of £4.3 million drawn was made for 16.7% of Jollyes, the UK's number two pet shop chain. This deal led by Kester Capital has some similarities to the Pet Centar investment in that it is also a play on the increased spend on pets, however there is also a strong professionalisation aspect to the investment thesis with a new but highly experienced management team coming in to enhance the UK number two pet shop chain.

 

Our longstanding link with Inflexion afforded us the opportunity to invest alongside them in North Wales based builders' merchant Huws Gray. This is a minority capital deal where we are investing alongside the Inflexion Partnership Capital Fund. Our share of the company is 1.8 per cent and £4.4 million of the total likely commitment of £6.0 million was invested in May. The investment thesis is that the company, which already has excellent financial metrics, should continue its accumulation of builders' merchants' outlets and small chains in contiguous areas whilst looking to make one or more larger acquisitions over the next three years or so.

 

The most recent co-investment was for £4.0 million into DMC Canotec, a Lyceum Capital led buyout of one of the UK's leading PMS (Print Managed Solutions) providers. The company is a leading distributor of Canon Photocopiers and associated services. Our investment gives us 7.9 per cent of the company. Contrary to the belief of proponents of the 'paperless office' printed documents continue to grow robustly with the scope for companies to do more of their own printing being enhanced by more advanced printers and services.

 

In addition to these new deals there was a substantial add on for TWMA, the Aberdeen based oil services company specialising in processing drill cuttings. £2.2 million was called by deal leaders Buckthorn for the acquisition by TWMA of US based Dynamic Oil Field Services. This gives the company a significant bridgehead into the important US onshore market at a competitive price.

 

Taking all these co-investments together amounts to £21.9 million of additional investment including the TWMA add on.

 

Drawdowns from the funds has been a relatively modest £14.9 million. The investee companies are as heterogeneous as ever. The most recent significant ones are noted below.

 

In the UK Apiary Capital Partners I has made its first investment which is The Appointment Group (TAG), which provides travel management services to the global music touring and entertainment industry as well as to the corporate sector. £0.6 million has been called. August Equity Partners IV has called £0.4 million for investment into British Assessment Bureau (BAB) a standards, certification and training provider. FPE Fund II called £0.3 million for project Visante a leading value-added reseller of Microsoft enterprise resource planning software. In other parts of Europe Astorg VI has invested £0.7 million in two companies; HRA Compeed, a French headquartered blister plaster company, and Italy based Surfaces Group which makes abrasive pads for polishing tiles. Montefiore IV has invested £0.4 million in Cruiseline, a Monaco based online travel agent with around 50 per cent of its business originating in France with the other 50 per cent derived internationally. Lastly in North America Blue Point Capital III called £0.5 million for investment in two companies; FM Sylvan is an industrial pipe fabricator and installer as well as a provider, amongst other things, of boiler and turbine contracting services operating from facilities in Michigan, New Jersey, Tennessee and Ontario; Spector is a supplier of promotional pens, booklets and bags headquartered in Montreal.

 

Realisations

Total realisations in the first half amounted to £29.9 million. This compares with £26.8 million at the same point last year.

 

Earlier in the year the Company benefitted from some excellent exits from different parts of the portfolio. Notable exits were August Equity II's sale of healthcare company Active Assistance (£3.1 million, 4.7x cost, 28 per cent IRR), Argan Capital's sale of fruit juice company Hortex (£2.1 million, 2.0x cost, 9 per cent IRR) and Procuritas Capital IV's sale ice cream machine manufacturer GRAM (Green Magnum) (£2.2 million, 6.5x cost, 44 per cent IRR).

 

Realisations have continued at a healthy pace more recently. The largest realisation of the quarter came from Polish buyout fund Avallon MBO Fund II which has sold its first holding, tissue paper company Velvet to Central Europe Private Equity House Abris. Our share of the proceeds is £1.7 million which represents an excellent return of 13.3x cost and an IRR of 67 per cent. August Equity Partners III recapitalised its veterinary practice chain Vet Partners earlier in the year and the proceeds of that were distributed to us during the quarter. Our share was £1.7 million representing 3.9x cost and including a residual position is 4.9x cost with an IRR of 141% as at 30 June 2018. In Finland Vaaka Partners Buyout Fund II sold IT Consultant Solita to Apax Digital returning £1.6 million, a hugely impressive 10.3x cost and an IRR of 59 per cent. £1.2 million came in from SEP III. This was the final proceeds from the sale of the Ctrip shares which were received as consideration for Skyscanner, a truly superb investment.

 

There were a number of other European exits. In Italy, machinery hydraulics company Faster has been sold by Capvis IV to a US trade buyer. Our share was £1.0 million which represents 2.8x cost and an IRR of 34 per cent. Progessio II sold adhesives company Industrie Chimiche Forestali (ICF) returning £0.5 million (1.9x cost, IRR 33 per cent). NEM Imprese III returned £0.5 million from the sale of electronic systems company Metafin and industrial plant company Boata. In Spain N+1 Private Equity Fund II sold aerospace and broadcasting company TRYO Group to industrial buyer Sener Aeronautica returning £0.8 million (3.7x cost, IRR 34 per cent). In France Chequers Capital XVI returned £0.6 million from the sale of landscaping service provider Idverde to Core Equity Holdings (2.8x cost, IRR 33 per cent). Ciclad 4 returned £0.6 million from the sale of publishing company Editiabys (0.6x cost) and construction safety equipment company Copac (3.6x cost,19.3 per cent IRR). Back in the UK clothing company Weird Fish repaid some of its loan stock which, including interest, gave us £0.5 million.

 

As can be seen these small but valuable distributions evidence a highly active market across Europe.

 

Valuation Changes

The largest valuation change over the period was for the NEM Imprese III portfolio which was up by £2.7 million following a revaluation to the fair market value after having been bought as a secondary at a discount. Weird Fish has made good progress and this co-investment is up by £2.3 million. Actual or pending realisations as well as strong trading have otherwise been the main recent positive influences. These were spread across the portfolio. Argan Capital is up by £0.6 million with the exits of two of its remaining three investments imminent. The exit of Solita noted above contributed to a good uplift of £0.4 million for Vaaka Partners Buyout Fund II. Ciclad 5 is up by £0.4 million mainly due to strong trading of its construction equipment rental business Valeco. Corpfin Capital Fund IV is up by £0.7 million reflecting strong trading of constituent companies. The Italian co-investment in travel company Alpitour, which is also held through ILP III, part of the Italian Portfolio, was sold in July to two of its Italian shareholders, returning a total of £3.0 million (2.0x cost, 37 per cent IRR) giving an uplift of £0.3 million. Recover Nordic, our co-investment in the insurance services market, is trading well and is up by £0.4 million.

 

There have been some downgrades during the first half. In the most recent quarter there are a few worth highlighting. In the Nordic region Procuritas Capital IV is down by £0.4 million reflecting some loss of momentum by supported living business Olivia. Herkules Private Equity III, a Norway based fund, has also had a weak quarter mainly due to continuing problems with sportswear company Odlo and it is down by £0.4 million. Pentech Fund II is down by £0.4 million reflecting the valuation basis on which FanDuel, the Sports Fantasy betting company has agreed a merger with the US operations of UK Listed PPB which is somewhat below the latest valuation.

 

Financing

The Company has moved into a modest net debt position as the co-investment programme has meant that deployment of capital has exceeded the flow of distributions temporarily. Current gearing stands at just below 7% with the borrowing facilities being partially utilised. The run rate of realisations suggests that another year of £50m+ is likely (2017: £65.1 million). The recent quarter has been busy for co-investment activity but for the year to date we have made five new co-investments which is broadly in line with our usual rate. We would expect the Company to remain moderately geared by the year end. The borrowing facilities expire next June and we will shortly be commencing discussions about a renewal or replacement facility.

 

Outlook

From our level of portfolio activity, it is clear that the private equity market is very active across Europe and further afield. The recurrent topic of comment is whether pricing levels, which appear to be high historically, will be sustained and whether this poses a longer-term threat to private equity returns. Price rises of this type are usually self-correcting with the first indicator being a reduction in the volume of deals. There is some evidence that this first stage is happening as deal volumes appear to have peaked last year. The headline price at which deals are done is only part of the picture as increasingly managers make add-on acquisitions to their initial 'platform' investments usually at lower prices bringing their 'in price' down significantly. As we have a portfolio that is well diversified by vintage a buoyant market with plenty of exits usually provides many opportunities for the value created by our investment partners to be crystallised. This is obviously helpful immediately from a financial point of view but also helps us to assess our investment partners implementation of their various investment theses in a very concrete way. The track record of our investment partners is the key determinant of whether we will back them in the first place and will continue to back them. Active market phases provide plenty of reference points for this assessment.

 

Taking into account the recent and developing exits in our portfolio, as well as the fundamental progress of our investments, we expect that the second half of the year will see further growth in NAV.

 

Hamish Mair

Investment Manager

F&C Investment Business Limited

 

 

(1) Calculated as dividends of 3.57p paid on 31 July 2018 and 3.57p payable on 31 October 2018 annualised divided by the Company's share price as at 30 June 2018.

 

(2) Borrowings less cash/total assets less current liabilities (excluding borrowings and cash)

 

 

F&C Private Equity Trust plc

 

Statement of Comprehensive Income for the

half year ended 30 June 2018

 

 

Unaudited

 

 

Revenue

£'000

Capital

£'000

Total

£'000

Income

 

 

 

Gains on investments held at fair value

-

8,387

8,387

Exchange gains

-

98

98

Investment income

495

-

495

Other income

40

-

40

Total income

535

8,485

9,020

 

 

 

 

Expenditure

 

 

 

Investment management fee - basic fee

(320)

(961)

(1,281)

Investment management fee - performance fee

-

(2,032)

(2,032)

Other expenses

(387)

-

(387)

Total expenditure

(707)

(2,993)

(3,700)

 

 

 

 

(Loss)/profit before finance costs and taxation

(172)

5,492

5,320

 

 

 

 

Finance costs

(210)

(631)

(841)

 

 

 

 

(Loss)/profit before taxation

(382)

4,861

4,479

 

 

 

 

Taxation

-

-

-

 

 

 

 

(Loss)/profit for period/total comprehensive income

(382)

4,861

4,479

 

 

 

 

Return per Ordinary Share

(0.52)p

6.58p

6.06p

 

The total column is the profit and loss account of the Company.

 

All revenue and capital items in the above statement derive from continuing operations.

 

 

 

F&C Private Equity Trust plc

 

Statement of Comprehensive Income for the

half year ended 30 June 2017

 

 

Unaudited

 

 

Revenue

£'000

Capital

£'000

Total

£'000

Income

 

 

 

Gains on investments held at fair value

-

14,509

14,509

Exchange losses

-

(761)

(761)

Investment income

151

-

151

Other income

23

-

23

Total income

174

13,748

13,922

 

 

 

 

Expenditure

 

 

 

Investment management fee - basic fee

(317)

(951)

(1,268)

Investment management fee - performance fee

-

(2,325)

(2,325)

Other expenses

(388)

-

(388)

Total expenditure

(705)

(3,276)

(3,981)

 

 

 

 

(Loss)/profit before finance costs and taxation

(531)

10,472

9,941

 

 

 

 

Finance costs

(211)

(632)

(843)

 

 

 

 

(Loss)/profit before taxation

(742)

9,840

9,098

 

 

 

 

Taxation

-

-

-

 

 

 

 

(Loss)/profit for period/total comprehensive income

(742)

9,840

9,098

 

 

 

 

Return per Ordinary Share

(1.01)p

13.31p

12.30p

 

 

The total column is the profit and loss account of the Company.

 

All revenue and capital items in the above statement derive from continuing operations.

 

F&C Private Equity Trust plc

 

Statement of Comprehensive Income for the

year ended 31 December 2017

 

 

 

(Audited)

 

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

 

 

 

Gains on investments held at fair value

-

21,216

21,216

Exchange losses

-

(1,019)

(1,019)

Investment income

1,422

-

1,422

Other income

51

-

51

Total income

1,473

20,197

21,670

 

 

 

 

Expenditure

 

 

 

Investment management fee - basic fee

(641)

(1,922)

(2,563)

Investment management fee - performance fee

-

(2,037)

(2,037)

Other expenses

(830)

-

(830)

Total expenditure

(1,471)

(3,959)

(5,430)

 

 

 

 

Profit before finance costs and taxation

2

16,238

16,240

 

 

 

 

Finance costs

(428)

(1,283)

(1,711)

 

 

 

 

(Loss)/profit before taxation

(426)

14,955

14,529

 

 

 

 

Taxation

-

-

-

 

 

 

 

(Loss)/profit for year/total comprehensive income

(426)

14,955

14,529

 

 

 

 

Return per Ordinary Share

(0.58)p

20.23p

19.65p

 

 

 

 

 

The total column is the profit and loss account of the Company.

 

All revenue and capital items in the above statement derive from continuing operations.

 

 

F&C Private Equity Trust plc

 

Amounts Recognised as Dividends

 

 

 

 

 

Six months ended 30 June 2018 (unaudited)

£'000

Six months ended 30 June 2017 (unaudited)

£'000

 

Year ended 31 December 2017

(audited)

£'000

Final Ordinary Share dividend of 6.48p per share for the year ended 31 December 2016

-

4,791

4,791

Interim Ordinary Share dividend of 6.92p per share for the year ended 31 December 2017

-

-

5,117

Quarterly Ordinary Share dividend of 3.55p per share for the year ended 31 December 2017

2,624

-

 

-

Quarterly Ordinary Share dividend of 3.57p per share for the year ended 31 December 2017

2,640

 

 

 

5,264

4,791

9,908

 

 

 

 

F&C Private Equity Trust plc

 

Balance Sheet

 

 

As at 30 June 2018

(unaudited)

As at 30 June 2017(unaudited)As at 31 December 2017

(audited)

 

£'000

£'000

 £'000

Non-current assets

 

 

 

Investments at fair value through profit or loss

286,352

258,801

266,536

 

 

 

 

Current assets

 

 

 

Other receivables

32

88

232

Cash and cash equivalents

7,017

34,195

26,765

 

7,049

34,283

26,997

 

 

 

 

Current liabilities

 

 

 

Other payables

(3,726)

(3,342)

(3,081)

Net current assets

3,323

30,941

23,916

Total assets less current liabilities

289,675

289,742

290,452

 Non-current liabilities

 

 

 

Interest-bearing bank loan

(26,316)

(25,912)

(26,308)

Net assets

263,359

263,830

264,144

 

 

 

 

Equity

 

 

 

Called-up ordinary share capital

739

739

739

Share premium account

2,527

2,527

2,527

Special distributable capital reserve

15,040

15,040

15,040

Special distributable revenue reserve

31,403

31,403

31,403

Capital redemption reserve

1,335

1,335

1,335

Capital reserve

212,697

212,786

213,100

Revenue reserve

(382)

-

-

Shareholders' funds

263,359

263,830

264,144

 

 

 

 

Net asset value per Ordinary Share

356.17p

356.81p

357.23p

 

 

F&C Private Equity Trust plc

Statement of Changes in Equity

 

 

 

 

 

Share Capital

 

Share Premium Account

Special Distributable Capital Reserve

Special Distributable Revenue Reserve

 

Capital Redemption Reserve

 

 

Capital Reserve

 

 

Revenue Reserve

 

 

 

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

For the six months ended 30 June 2018 (unaudited)

 

 

 

 

 

 

 

 

 

 

Net assets at 1 January 2018

739

2,527

15,040

31,403

1,335

213,100

-

264,144

Profit/(loss) for the period/total comprehensive income

 

-

 

-

 

-

 

-

 

-

 

4,861

 

(382)

 

4,479

Dividends paid

-

-

-

-

-

(5,264)

-

(5,264)

 

 

 

 

 

 

 

 

 

 

Net assets at 30 June 2018

739

2,527

15,040

31,403

1,335

212,697

(382)

263,359

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the six months ended 30 June 2017 (unaudited)

 

 

 

 

 

 

 

 

 

 

Net assets at 1 January 2017

739

2,527

15,040

31,403

1,335

203,679

4,800

259,523

Profit/(loss) for the period/total comprehensive income

 

-

 

-

 

-

 

-

 

-

 

9,840

 

(742)

 

9,098

Dividends paid

-

-

-

-

-

(733)

(4,058)

(4,791)

 

 

 

 

 

 

 

 

 

 

Net assets at 30 June 2017

739

2,527

15,040

31,403

1,335

212,786

-

263,830

 

 

For the year ended 31 December 2017 (audited)

 

 

 

 

 

 

 

 

 

 

Net assets at 1 January 2017

739

2,527

15,040

31,403

1,335

203,679

4,800

259,523

Profit/(loss) for the year/total comprehensive income

 

-

 

-

 

-

 

-

 

-

 

14,955

 

(426)

 

14,529

Dividends paid

-

 -

-

-

-

(5,534)

(4,374)

(9,908)

 

 

 

 

 

 

 

 

 

 

Net assets at 31 December 2017

739

2,527

15,040

31,403

1,335

213,100

-

264,144

 

 

 

 

 

 

 

 

 

 

F&C Private Equity Trust plc

 

Cash Flow Statement

 

 

 

Six months ended

30 June 2018

(unaudited)

Six months ended

30 June 2017

(unaudited)

Year ended

31 December 2017

(audited)

 

£000

£000

£000

 

 

 

 

Operating activities

 

 

 

Profit before taxation

4,479

9,098

14,529

Gains on disposals of investments

(13,525)

(12,756)

(32,637)

Decrease/ (increase) in holding gains

5,138

(1,753)

11,421

Exchange differences

(98)

761

1,019

Interest income

(40)

(23)

(51)

Interest received

40

23

51

Investment income

(495)

(151)

(1,422)

Dividends received

495

151

1,422

Finance costs

841

843

1,711

(Increase)/decrease in other receivables

(6)

(62)

1

Increase in other payables

655

285

26

 

Net cash outflow from operating activities

 

(2,516)

 

(3,584)

 

(3,930)

 

 

 

 

Investing activities

 

 

 

Purchases of investments

(40,528)

(31,622)

(69,546)

Sales of investments

29,306

26,379

63,068

 

Net cash outflow from investing activities

 

(11,222)

 

(5,243)

 

(6,478)

Financing activities

 

 

 

Shares issued

-

-

-

Interest paid

(743)

(735)

(1,497)

Equity dividends paid

(5,264)

(4,791)

(9,908)

 

Net cash outflow from financing activities

(6,007)

(5,526)

 

(11,405)

 

Net decrease in cash and cash equivalents

 

(19,745)

 

(14,353)

 

(21,813)

Currency (losses)/gains

(3)

(27)

3

 

Net decrease in cash and cash equivalents

 

(19,748)

 

(14,380)

 

(21,810)

Opening cash and cash equivalents

26,765

48,575

48,575

 

Closing cash and cash equivalents

 

7,017

 

34,195

 

26,765

 

 

 

 

 

 

 

Statement of Principal Risks and Uncertainties

 

 

The Directors believe that the principal risks and uncertainties faced by the Company include investment, strategic, external, regulatory, operational, financial and funding. The Company is also exposed to risks in relation to its financial instruments. These risks, and the way in which they are managed, are described in more detail under the heading Principal Risks and Uncertainties and Risk Management within the Business Model, Strategy and Policies Section in the Annual Report for the year ended 31 December 2017. The Company's principal risks and uncertainties have not changed materially since the date of that report and are not expected to change materially for the remaining six months of the Company's financial year.

 

Statement of Directors' Responsibilities in Respect of the Half Year Report

 

We confirm that to the best of our knowledge:

 

· the condensed set of financial statements have been prepared in accordance with IAS 34 'Interim Financial Reporting' and give a true and fair view of the assets, liabilities, financial position and profit of the Company;

 

· the Chairman's Statement and Manager's Review (together constituting the Interim Management Report) include a fair review of the information required by the Disclosure and Transparency Rules ('DTR') 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the financial statements;

 

· the Statement of Principal Risks and Uncertainties shown above is a fair review of the information required by DTR 4.2.7R; and

 

· the condensed set of financial statements include a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the financial year and that have materially affected the financial position or performance of the Company during the period, and any changes in the related party transactions described in the last Annual Report that could do so.

 

 

On behalf of the Board

 

 

Mark Tennant

Chairman

 

 

Notes (unaudited)

 

1. The condensed company financial statements have been prepared on a going concern basis in accordance with International Financial Reporting Standard ('IFRS') IAS 34 'Interim Financial Reporting' and the accounting policies set out in the statutory accounts for the year ended 31 December 2017. The condensed financial statements do not include all of the information and disclosures required for a complete set of IFRS financial statements and should be read in conjunction with the financial statements for the year ended 31 December 2017, which were prepared under full IFRS requirements.

 

2. Earnings for the six months to 30 June 2018 should not be taken as a guide to the results for the year to 31 December 2018.

 

3. Investment management fee:

 

 

 

Six months to

30 June 2018

(unaudited)

 

 

Six months to

30 June 2017

(unaudited)

 

 

Year ended

31 December 2017

(audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Investment management fee - basic fee

320

961

1,281

317

951

1,268

641

1,922

2,563

Investment management fee - performance fee

-

2,032

2,032

-

2,325

2,325

-

2,037

2,037

 

 

 

 

 

 

 

 

 

 

 

320

2,993

3,313

317

3,276

3,593

641

3,959

4,600

 

 

 

 

 

 

 

 

 

 

 

4. Finance costs:

 

 

 

Six months to

30 June 2017

(unaudited)

 

 

Six months to

30 June 2016

(unaudited)

 

 

Year ended

31 December 2017

(audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Interest payable on bank loans

210

631

841

 

211

632

843

428

1,283

1,711

 

 

 

 

 

 

 

 

 

 

 

5. The return per Ordinary Share is based on a net profit on ordinary activities after taxation of £4,479,000 (30 June 2017 - £9,098,000; 31 December 2017 - £14,529,000) and on 73,941,429 (30 June 2017 -73,941,429; 31 December 2017 -73,941,429) shares, being the weighted average number of Ordinary Shares in issue during the period.

 

 

6. The net asset value per Ordinary Share is based on net assets at the period end of £263,359,000 (30 June 2017 - £263,830,000; 31 December 2017 - £264,144,000) and on 73,941,429 (30 June 2017 - 73,941,429; 31 December 2017 - 73,941,429) shares, being the number of Ordinary Shares in issue at the period end.

 

 

7. The fair value measurements for financial assets and liabilities are categorised into different levels in

the fair value hierarchy based on inputs to valuation techniques used. The different levels are defined as follows:

 

Level 1 reflects financial instruments quoted in an active market.

 

Level 2 reflects financial instruments whose fair value is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique whose variables includes only data from observable markets.

 

Level 3 reflects financial instruments whose fair value is determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable market transactions in the same instrument and not based on available observable market data.

 

 

 

 

 

 

Level 1

Level 2

Level 3

Total

 

£'000

£'000

£'000

£'000

 

30 June 2018

 

 

 

 

 

 

 

 

 

Financial assets

800

-

285,552

286,352

Investments

 

Financial liabilities

Interest-bearing bank loan

 

 

 

-

 

 

 

(26,539)

 

 

 

-

 

 

 

(26,539)

 

 

 

 

 

30 June 2017

 

 

 

 

 

 

 

 

 

Financial assets

1,083

-

257,718

258,801

Investments

 

Financial liabilities

Interest-bearing bank loan

 

 

 

-

 

 

 

(26,405)

 

 

 

-

 

 

 

(26,405)

 

 

 

 

 

31 December 2017

 

 

 

 

 

 

 

 

 

Financial assets

 

 

 

 

Investments

 

Financial liabilities

Interest-bearing bank loan

956

 

 

-

-

 

 

(26,643)

265,580

 

 

-

266,536

 

 

(26,643)

 

 

 

 

 

 

 

 

 

 

There were no transfers between levels in the fair value hierarchy in the period ended 30 June 2018. Transfers between levels of the fair value hierarchy are deemed to have occurred at the date of the event that caused the transfer.

 

Valuation techniques

Quoted fixed asset investments held are valued at bid prices which equate to their fair values. When fair values of publicly traded equities are based on quoted market prices in an active market without any adjustments, the investments are included within Level 1 of the hierarchy. The Company invests primarily in private equity funds and co-investments via limited partnerships or similar fund structures. Such vehicles are mostly unquoted and in turn invest in unquoted securities. The fair value of a holding is based on the Company's share of the total net asset value of the fund or share of the valuation of the co-investment calculated by the lead private equity manager on a quarterly basis. The lead private equity manager derives the net asset value of a fund from the fair value of underlying investments. The fair value of these underlying investments and the Company's co-investments is calculated using methodology which is consistent with the International Private Equity and Venture Capital Valuation Guidelines ('IPEG'). In accordance with IPEG these investments are generally valued using an appropriate multiple of maintainable earnings, which has been derived from comparable multiples of quoted companies or recent transactions. The F&C private equity team has access to the underlying valuations used by the lead private equity managers including multiples and any adjustments. The F&C private equity team generally values the Company's holdings in line with the lead managers but may make adjustments where they do not believe the underlying managers' valuations represent fair value. On a quarterly basis, the F&C private equity team present the valuations to the Board. This includes a discussion of the major assumptions used in the valuations, which focuses on significant investments and significant changes in the fair value of investments. If considered appropriate, the Board will approve the valuations.

 

The interest-bearing bank loan is recognised in the Balance Sheet at amortised cost in accordance with IFRS. The fair value of the loan is based on indicative break costs. The fair values of all of the Company's other financial assets and liabilities are not materially different from their carrying values in the balance sheet.

 

Significant unobservable inputs for Level 3 valuations

The Company's unlisted investments are all classified as Level 3 investments. The fair values of the unlisted investments have been determined principally by reference to earnings multiples, with adjustments made as appropriate to reflect matters such as the sizes of the holdings and liquidity. The weighted average earnings multiple for the portfolio as at 30 June 2018 was 8.7 times EBITDA (Earnings Before Interest, Tax, Depreciation and Amortisation) (30 June 2017: 8.0 times EBITDA; 31 December 2017: 8.7 times EBITDA).

 

The significant unobservable input used in the fair value measurement categorised within Level 3 of the fair value hierarchy together with a quantitative sensitivity analysis are shown below:

 

Period ended

Input

Sensitivity used*

Effect on fair value £'000

30 June 2018

Weighted average earnings multiple

1x

52,064

30 June 2017

Weighted average earnings multiple

1x

49,561

31 December 2017

Weighted average earnings multiple

1x

48,287

* The sensitivity analysis refers to an amount added or deducted from the input and the effect this has on the fair value.

 

The fair value of the Company's unlisted investments are sensitive to changes in the assumed earnings multiples. The managers of the underlying funds assume an earnings multiple for each holding. An increase in the weighted average earnings multiple would lead to an increase in the fair value of the investment portfolio and a decrease in the multiple would lead to a decrease in the fair value.

 

The following table shows a reconciliation of all movements in the fair value of financial instruments categorised within Level 3 between the beginning and the end of the period:

 

 

30 June 2018

30 June 2017

31 December 2017

 

£'000

£'000

£'000

Balance at beginning of period

265,580

238,505

238,505

Purchases

40,528

31,052

69,339

Sales

(29,099)

(25,809)

(63,068)

Gains on disposal

13,525

12,756

32,637

In specie distribution

-

(570)

(570)

Increase in holding (losses)/gains

(4,982)

1,784

(11,263)

Balance at end of period

285,552

257,718

268,580

 

8. In assessing the going concern basis of accounting the Directors have had regard to the guidance issued by the Financial Reporting Council. They have considered the current cash position of the Company, the availability of the Company's loan facility and compliance with its covenants. They have also considered forecast cash flows, especially those relating to capital commitments and realisations.

 

As at 30 June 2018, the Company had outstanding undrawn commitments of £142.4 million. Of this amount, approximately £16.7 million is to funds where the investment period has expired and the Manager would expect very little of this to be drawn. Of the outstanding undrawn commitments remaining within their investment periods, the Manager would expect that a significant amount will not be drawn before these periods expire.

 

Based on this information the Directors believe the Company has the ability to meet its financial obligations as they fall due for a period of at least twelve months from the date of approval of the accounts. Accordingly, the accounts have been prepared on a going concern basis.

 

 

9. These are not statutory accounts in terms of Section 434 of the Companies Act 2006 and have not been audited or reviewed by the Company's auditors. The information for the year ended 31 December 2017 has been extracted from the latest published financial statements which received an unqualified audit report and have been filed with the Registrar of Companies. No statutory accounts in respect of any period after 31 December 2017 have been reported on by the Company's auditors or delivered to the Registrar of Companies. The Half-Year Report is available at the Company's website address, www.fcpet.co.uk.

 

 

 

For more information, please contact:

 

Hamish Mair (Fund Manager)

0131 718 1184

hamish.mair@bmogam.com

 

Scott McEllen (Company Secretary)

 

0131 718 1137

scott.mcellen@bmogam.com

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR BLGDIIBDBGIX
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.